By

Sara Dagen

Cannabix Technologies Correlates THC in Breath and Blood Using Proprietary Sample Collection and Analysis Hardware in Experimental Study

UF startup Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports it has successfully tested a supplemental version of its FAIMS technology for detection of ∆9-tetrahydrocannabinol (“THC”) and related analytes in human breath in an independent experimental study.

Research to Renewal: Advancing University Tech Transfer

The American research university is a unique institution that much of the world has long tried to emulate. Many times under-appreciated in the U.S., research universities are one of the most important knowledge assets of cities and states for economic development purposes. These universities influence the economic prospects of their regions and the nation overall in multiple ways. That said, ranking overall in second place, the University of Florida is the top public university on this list.

A First: Scientists Grow Plants in Soil From the Moon

Scientists have grown plants in soil from the moon, a first in human history and a milestone in lunar and space exploration. In a new paper published in the journal “Communications Biology,” University of Florida researchers showed that plants can successfully sprout and grow in lunar soil. Their study also investigated how plants respond biologically to the moon’s soil, also known as lunar regolith, which is radically different from soil found on Earth.

CITI Program and Biotility at UF Announce Partnership

The Collaborative Institutional Training Initiative (CITI Program), the leader in online research, ethics, and compliance training, and Biotility at the University of Florida announced an exclusive licensing agreement to offer select Biotility’s biotech training courses on CITI Program’s learning platform.

Genascence Announces First Close in Series a Financing Led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, today announced it has completed the first closing in a Series A financing led by Pacira BioSciences, Inc., totaling $10.5 million. As part of the financing, UF Innovate's Jackson Streeter, joins Genascence's board of directors.